These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30012535)

  • 41. Erratum to: Mathilda L. Bongers, Veerle M.H. Coupé, Dirk De Ruysscher, Cary Oberije, Philippe Lambin, and Cornelia A. Uyl-de Groot. Individualized Positron Emission Tomography-Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy: A Model-Based Evaluation. Int J Radiat Oncol Biol Phys 2015;91:857-865.
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1175. PubMed ID: 26194686
    [No Abstract]   [Full Text] [Related]  

  • 42. Erratum to: Zeng Y, Liu Q, Wang Y, et al. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer. Int J Radiat Oncol Biol Phys 2020;108(3):758-769.
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1030-1031. PubMed ID: 38851263
    [No Abstract]   [Full Text] [Related]  

  • 43. Erratum to: van der Velden JM, Peters M, Verlaan J-J, Versteeg AL, Zhang L, Tsao M, Danjoux C, Barnes E, van Vulpen M, Chow E, Verkooijen HM. Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases. Int J Radiat Oncol Biol Phys 2017;99:859-866.
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1186. PubMed ID: 31327423
    [No Abstract]   [Full Text] [Related]  

  • 44. Erratum to: Wilkins AC, Gusterson B, Szijgyarto Z, et al. Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2018;101:309-315.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967236
    [No Abstract]   [Full Text] [Related]  

  • 45. Erratum to: Dawei Chen, Vivek Verma, Roshal R. Patel, et al. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials. Int J Radiat Oncol Biol Phys 2020:108(1);196-203.
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):623. PubMed ID: 33989592
    [No Abstract]   [Full Text] [Related]  

  • 46. Toward a unified survival curve: in regard to Kavanagh and Newman (Int J Radiat Oncol Biol Phys 2008;71:958-959) and Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852).
    McKenna F; Ahmad S
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):640; author reply 640-1. PubMed ID: 19147035
    [No Abstract]   [Full Text] [Related]  

  • 47. Erratum to: Anker CJ, Grossmann KF, Atkins MB, Suneja G, Tarhini AA, Kirkwood JM. Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: Consensus guidelines from the Eastern Cooperative Oncology Group (ECOG). Int J Radiat Oncol Biol Phys 2016;95:632-646.
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):486. PubMed ID: 27598818
    [No Abstract]   [Full Text] [Related]  

  • 48. Erratum to: Yuan Zhuang, Yuzi Wang, Guang Li, et al. Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes with Radiation and PD-1 Blockade. Int J Radiat Oncol Biol Phys 2023;116(4):894-905.
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1032-1033. PubMed ID: 38851264
    [No Abstract]   [Full Text] [Related]  

  • 49. Erratum to: Rodrigues G, Oberije C, Senan S, et al. is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small cell lung cancer beneficial? A multi-institutional propensity score matched analysis. Int J Radiat Oncol Biol Phys 2015;91:133-139.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832709
    [No Abstract]   [Full Text] [Related]  

  • 50. Erratum to: Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)  Int J Radiat Oncol Biol Phys 2020;108:1399-1400.
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):698. PubMed ID: 37270256
    [No Abstract]   [Full Text] [Related]  

  • 51. Erratum to: Wilson JF, Buchholz TA, and Komaki R. James Daniel Cox, MD, FASTRO, FACR. Int J Radiat Oncol Biol Phys 2019;103:784-785.
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):470. PubMed ID: 31047635
    [No Abstract]   [Full Text] [Related]  

  • 52. Erratum to: Kanehira T, Matsuura T, Takao S, et al. Impact of Real-Time-Image Gating on Spot Scanning Proton Therapy for Lung Tumors: A Simulation Study. Int J Radiat Oncol Biol Phys 2016;97:173-181.
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):280. PubMed ID: 29254779
    [No Abstract]   [Full Text] [Related]  

  • 53. Erratum to: Heumann TR, Esiashvili N, Parker S, et al. Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique. Int J Radiat Oncol Biol Phys 2015;92:183-191.
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):729-30. PubMed ID: 26461023
    [No Abstract]   [Full Text] [Related]  

  • 54. Erratum to: Walshaw RC, Hoskin PJ, Choudhury A. Can Hypofractionation and Immune Modulation Coexist? Int J Radiat Oncol Biol Phys 2021;110(3):742-744.
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):587. PubMed ID: 34473989
    [No Abstract]   [Full Text] [Related]  

  • 55. Erratum to: Mohan R, Held KD, Story MD, et al. Proceedings of the National Cancer Institute Workshop on Charged Particle Radiobiology. Int J Radiat Oncol Biol Phys 2018;100:816-831.
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):1004. PubMed ID: 29976478
    [No Abstract]   [Full Text] [Related]  

  • 56. Erratum to: Al-Hallaq H, Cao M, Kruse J, Klein E. Cured in a FLASH: Reducing Normal Tissue Toxicities Using Ultra-High-Dose Rates. Int J Radiat Oncol Biol Phys 2019;104:257-260.
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1186. PubMed ID: 31327422
    [No Abstract]   [Full Text] [Related]  

  • 57. Erratum for Dominello MM, Sanders T, Anscher M, et al. "Responses to the 2018 and 2019 "One Big Discovery" Question: ASTRO Membership's Opinions on the Most Important Research Question Facing Radiation Oncology…Where Are We Headed?" Int J Radiat Oncol Biol Phys 2021;109:38-40.
    Int J Radiat Oncol Biol Phys; 2023 Jun; 116(2):471. PubMed ID: 37179101
    [No Abstract]   [Full Text] [Related]  

  • 58. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271).
    Kavanagh BD; Newman F
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):958-9. PubMed ID: 18514788
    [No Abstract]   [Full Text] [Related]  

  • 59. Erratum to: Jabbari S, Fitzmaurice T, Munoz F, et al. Cross-Border Collaboration in Oncology: A Model for United States-Mexico Border Health. Int J Radiat Oncol Biol Phys 2015;92:509-511.
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):472. PubMed ID: 26383691
    [No Abstract]   [Full Text] [Related]  

  • 60. Retraction notice. Radiation therapy for macular degeneration: technical considerations and preliminary results. Int J Radiat Oncol Biol Phys 1997;39:945-8.
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):717-8. PubMed ID: 25304956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.